Quflora Pediatric Drops (CarWin Pharmaceutical Associates, LLC)


Welcome to the PulseAid listing for the Quflora Pediatric Drops drug offered from CarWin Pharmaceutical Associates, LLC. This Vitamin A [Chemical/Ingredient],Vitamin A [EPC],Vitamin D [Chemical/Ingredient],Vitamin D [EPC],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Vitamin B 12 [Chemical/Ingredient],Vitamin B12 [EPC],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: CarWin Pharmaceutical Associates, LLC
NON-PROPRIETARY NAME: VITAMIN A ACETATE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, D-, THIAMINE HYDROCHLORIDE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, LEVOMEFOLIC ACID, CYANOCOBALAMIN, MAGNESIU
SUBSTANCE NAME: VITAMIN A ACETATE; ASCORBIC ACID; CHOLECALCIFEROL; .ALPHA.-TOCOPHEROL ACETATE, D-; THIAMINE HYDROCHLORIDE; RIBOFLAVIN; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; LEVOMEFOLIC ACID; CYANOCOBALAMIN; MAGNESIU
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Vitamin A [Chemical/Ingredient],Vitamin A [EPC],Vitamin D [Chemical/Ingredient],Vitamin D [EPC],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Vitamin B 12 [Chemical/Ingredient],Vitamin B12 [EPC],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2014-07-15
END MARKETING DATE: 0000-00-00


Quflora Pediatric Drops HUMAN PRESCRIPTION DRUG Details:

Item DescriptionQuflora Pediatric Drops from CarWin Pharmaceutical Associates, LLC
LABELER NAME: CarWin Pharmaceutical Associates, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 1000; 35; 400; 5; .5; .6; .8; .4; 35; 2; 10; 1; .25([iU]/mL; mg/mL; [iU]/mL; [iU]/mL; mg/mL; mg/mL; mg/mL; mg/mL; ug/mL; ug/mL; mg/mL; mg/mL; mg/mL)
START MARKETING DATE: 2014-07-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 15370-100_967ee6d0-2450-4fd9-ac7a-992f0ff69b71
PRODUCT NDC: 15370-100
APPLICATION NUMBER:

Other VITAMIN A ACETATE; ASCORBIC ACID; CHOLECALCIFEROL; .ALPHA.-TOCOPHEROL ACETATE, D-; THIAMINE HYDROCHLORIDE; RIBOFLAVIN; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; LEVOMEFOLIC ACID; CYANOCOBALAMIN; MAGNESIU Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
CarWin Pharmaceutical Associates, LLCQuflora Pediatric Drops